<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:32:24Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/12653" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/12653</identifier><datestamp>2026-09-24T19:50:23Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Tarnopolsky, Mark</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Mocellin, Joseph Nicholas</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Medical Sciences</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T17:00:18Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T17:00:18Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2012-09-26</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2012-10</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/7520</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">8579</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">3352636</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/12653</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/13471</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>&lt;em>Objective: &lt;/em>We evaluated the potential effect of oral glucose supplementation on: (1) exercise performance and tolerance, (2) the concentrations of plasma uric acid and ammonia (NH&lt;sub>3&lt;/sub>) and (3) blood plasma markers of oxidative stress in patients with McArdle’s disease (MCD) after non-ischemic forearm exercise testing (non-ischemic forearm exercise test). &lt;em>Methods:&lt;/em> Blood samples and exercise performance measures were performed on from 16 patients with MCD and 17 control subjects (CON) matched for age, sex and physical activity status. Subjects performed 2 exercise bouts 30 minutes apart and received oral glucose or placebo supplementation between tests. Blood samples were analyzed for concentrations of 8-isoprostanes (8-ISO), malondialdehyde (MDA) and total anti-oxidant capacity (TEAC). Exercise performance was assessed using a handgrip dynamometer to measure force of contraction over time. Exercise tolerance was assessed based on subject’s self-reported perception of pain and perception of exertion during exercise. &lt;em>Results:&lt;/em> MCD was associated with greater fatigue, perceived pain, perceived exertion, and higher uric acid during non-ischemic forearm exercise test (P &lt; 0.05), and higher concentrations of plasma NH&lt;sub>3 &lt;/sub>post exercise (P &lt; 0.05). Glucose did not influence plasma uric acid or NH&lt;sub>3 &lt;/sub>and had no effect on exercise measures in MCD patients. Baseline plasma markers of oxidative stress were not different between MCD patients and CON; however, MCD patients who ingested glucose between non-ischemic forearm exercise tests had lower plasma 8-ISO concentrations (P &lt; 0.05). CON who ingested glucose between non-ischemic forearm exercise tests had lower plasma 8-ISO concentrations (P &lt; 0.05) at +1 min post exercise compared to initial non-ischemic forearm exercise test. The TEAC of control subjects was lower following non-ischemic forearm exercise test (P &lt; 0.05), with no change in MCD patients. &lt;em>Conclusion: &lt;/em>Glucose may have a protective effect on oxidative stress following exercise that may be due to attenuated flux through xanthine oxidase.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Master of Science (MSc)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">McArdles disease</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">oxidative stress</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">exercise</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">glucose supplementation</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biochemical Phenomena, Metabolism, and Nutrition</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Medical Nutrition</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biochemical Phenomena, Metabolism, and Nutrition</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">GLUCOSE SUPPLEMENTATION AND MEASURES OF OXIDATIVE STRESS IN PATIENTS WITH GLYCOGEN PHOSPHORYLASE DEFICIENCY (MCARDLE’S DISEASE).</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>